Niche Diagnostics IBL-America specializes in in-vitro diagnostic kits, antibodies, and proteins across autoimmune, brain research, endocrinology, infectious disease, neuroscience, oncology, and tumor markers, indicating ample opportunities to cross-sell additional assays, antibodies, and ELISA kits to existing customers and new labs within these fields.

Clinical Support Tie‑in With in-house technical support and a collaboration with KMI Diagnostics, leverage joint service offerings for complex testing and pre-clinical study support to expand adoption of higher‑margin panels and companion diagnostic solutions for medical devices and research.

Kidney Week Access Active participation as an exhibitor at Kidney Week 2025 positions the company to generate leads among nephrology researchers and clinicians; a targeted follow‑up strategy could promote relevant ELISAs, antibodies, and kits for renal studies and biomarkers.

Product Expansion History Past launches include Angiotensinogen ELISAs, Titin monoclonal antibodies, soluble receptor ELISAs, and autoantibody kits, suggesting a pattern of expanding niche assay portfolios that can be leveraged to upsell newer biomarkers to current customers.

Small but Agile With under 10 employees and revenues under one million, emphasize personalized account management, rapid response times, and modular kit offerings to win smaller labs and contract research organizations, while scaling through channel partnerships and sister‑company collaboration.